Apollo Cancer Centres launches blood-based multi-cancer detection test
Apollo Cancer Centres has launched a blood-based multi-cancer detection test in India in partnership with Zydus Lifesciences. The test, developed by Guardant Health, is designed to identify signals for ten different types of cancer in individuals aged 45 and older.
Why it matters
Advancements in non-invasive screening technology could significantly improve early cancer detection rates, though medical experts emphasize it should be used alongside professional guidance.
Apollo Cancer Centres (ACCs) on Friday launched a blood-based multi-cancer detection test in India after signing a memorandum of understanding (MoU) with Zydus Lifesciences to offer the screening technology, which was developed by Guardant Health.
The article provides a balanced report on a medical product launch, including necessary caveats from medical professionals.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in